As we prepare to move to a new office, we bid farewell to the old one. We have shared countless memories filled with laughter and accomplishments for the past 2 years. It’s the end of a chapter, and we look forward to the new opportunities that await us in our new home!

It was an honor speaking at the SDiPath Industry Fair in Bern! Our Head of Sales Maximilien Petit represented Primaa on the topic “AI solutions for the first read of breast cancer diagnosis in clinical practice”! #SDiPath #digitalpathology #pathology #AI #healthcareai

@PrimaaLab attended the MVA forum at the ENS Paris-Saclay, one of the most prestigious master's programs in #AI🗣️ Our onsite specialists met many students and professionals. They had the opportunity to present our latest technological advances in the field of #DigitalPathology!

The 9th Digital Pathology & AI Congress is next week, and Primaa will be present in London💡 Want to learn more about Primaa #AI and how it is being applied to primary diagnosis and #CancerResearch studies? Don’t hesitate to plan an in-person meeting 👉 rb.gy/qisl3x

Primaa sera présent lors de #CarrefourPathologie du 4 au 7 novembre prochain, au Palais des Congrès à Paris. Venez nous rencontrer lors de cette semaine pour échanger sur l'apport de l'#IA et du #DeepLearning dans le diagnostic en #anatomopathologie.

[ #MedTech ] Félicitation à l'équipe #Primaa, actuellement en incubation chez #Agoranov, qui lève 2 millions d'euros pour accélérer la détection des #cancers🎗️ ▶️ Plus d'info : bit.ly/2OATalp #Tech4Good #IA #OctobreRose

We are very proud and grateful to announce our fundraising in the field of #digitalpathology and #AI for a better and faster #cancer diagnosis #MEDTECH #ArtificialIntelligence #DeepLearning #WholeSlideImaging #pathology #breastcancer

Nous sommes très fiers et reconnaissants d'annoncer notre levée de fonds dans le domaine de la #digitalpathology, l'#AI, pour améliorer le diagnostic des #cancer #MEDTECH #ArtificialIntelligence #DeepLearning #WholeSlideImaging #pathology #breastcancer

« Nous allons diversifier l’activité en fonction du nombre de patients touchés par chacune des pathologies« , se projette Fanny Sockeel @PrimaaLab #MaddyMoney #MedTech buff.ly/2IFCipR